Spero Therapeutics News

Spero Therapeutics Analyst Ratings

BenzingaApr 4 21:44

Spero Therapeutics Analyst Ratings

BenzingaMar 18 19:01

Spero Therapeutics' Robust Drug Pipeline and Positive Trial Advancements Prompt Buy Rating

TipRanksMar 18 18:26

TD Cowen Sticks to Its Hold Rating for Spero Therapeutics (SPRO)

TipRanksMar 14 11:25

TD Cowen Keeps Their Hold Rating on Spero Therapeutics (SPRO)

TipRanksNov 18, 2023 03:25

Analysts Offer Insights on Healthcare Companies: Durect (DRRX), Spero Therapeutics (SPRO) and EFFECTOR Therapeutics (EFTR)

TipRanksNov 14, 2023 19:40

Spero Therapeutics Analyst Ratings

BenzingaNov 14, 2023 19:30

Buy Rating for Spero Therapeutics: Impact of New CFO and Imminent Phase 3 Trial Program

TipRanksNov 3, 2023 02:53

Spero Therapeutics (SPRO) Receives a Buy From H.C. Wainwright

TipRanksSep 5, 2023 18:25

Spero Therapeutics Analyst Ratings

BenzingaSep 5, 2023 18:14

HC Wainwright & Co. Maintains Buy on Spero Therapeutics, Raises Price Target to $7

BenzingaAug 14, 2023 18:22

Spero Therapeutics Analyst Ratings

BenzingaAug 14, 2023 18:21

H.C. Wainwright Reaffirms Their Buy Rating on Spero Therapeutics (SPRO)

TipRanksAug 1, 2023 18:25

HC Wainwright & Co. Reiterates Buy on Spero Therapeutics, Maintains $6 Price Target

BenzingaAug 1, 2023 18:22

Spero Therapeutics Analyst Ratings

BenzingaAug 1, 2023 18:21

Spero Therapeutics Analyst Ratings

BenzingaJul 20, 2023 18:39

Spero Therapeutics (SPRO) Receives a Buy From H.C. Wainwright

TipRanksJul 20, 2023 18:15

HC Wainwright & Co. Reiterates Buy on Spero Therapeutics, Maintains $6 Price Target

BenzingaApr 10, 2023 21:45

H.C. Wainwright Sticks to Its Buy Rating for Spero Therapeutics (SPRO)

TipRanksApr 10, 2023 20:50

H.C. Wainwright Remains a Buy on Spero Therapeutics (SPRO)

TipRanksJan 26, 2023 19:16